Mylan wants injunctions against Sun Pharma, Cipla over generic cholesterol drug
Intellectual Property 2019-03-06 3:17 pm By Christine Caulfield | Melbourne
Please login to bookmark Close

Mylan has renewed calls for a temporary injunction against Sun Pharma pending an appeal of a ruling invalidating its patents for Lipidil, and has sued a second generic drug maker, Cipla, over the cholesterol-lowering medication.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au